Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 8,080 shares at $6.25 ($51K) on 2019-08-20, disclosed to the SEC on 2019-08-21.
Seasonal sale ($50k) by President and CEO — this insider has traded GNMK in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |